Immunotherapies work by retraining the immune system, and scientists hope they can stop or prevent the immune attack behind Type 1 diabetes. Clinical trials testing immunotherapies are going on right ...

Some people with type 2 diabetes might have differences in how their brains get messages about sweet flavours. Dr Sally Eldeghaidy wants to find out more about why this is, by looking for signals in ...

Tiny variations in our genes can affect insulin receptors, which sit on the surface of our cells and allow insulin to enter. Problems with insulin receptors affect how our body responds to insulin and ...

Developing and Evaluating a Multifactorial Intervention to Improve Cardiovascular Outcomes in Adults with type 2 Diabetes and Current or Previous Diabetic Foot Ulcers (MiFoot) ...

We are excited to be bringing you six Wellness Walks across the UK in 2024.

In this series we take a look at some of the exciting diabetes research developments announced recently, and what the findings could mean for people living with or affected by diabetes. We bring to ...

Neuromuscular Electrical Stimulation For The Treatment Of Diabetic Neuropathy: A Multicentre, Double-blind, Pilot, Randomised, Sham-controlled Trial (NMES-DN) ...

In our August research highlights, we look at a study showing that a psoriasis medication might help to stop the type 1 immune attack, and how tiny blood vessels are impacted by sleep duration in type ...

Identifying the unique experiences of perimenopause and menopause amongst women with Type 1 or Type 2 diabetes to inform future practice ...

What you eat can affect how well you feel and how you manage your diabetes. Although there's no such thing as a diabetes diet or food plan, we've put together advice to help you make healthier choices ...

In our September research highlights, we look at studies presented at the annual European Association for the Study of Diabetes (EASD) conference in September, including how voice screening could be ...

We’re thrilled that 20,000 children have signed up to the ELSA (EarLy Surveillance for Autoimmune diabetes) study to understand their future risk of type 1 diabetes. Recruitment is still open and ...